Stephen M Wiesner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Stephen M Wiesner

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

American Journal of Hematology|June 18, 2011

Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeStephen M Wiesner, Jennifer L Geurts, Miechaleen D Diers, et al.

Stem Cells and Development|February 15, 2008

Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like propertiesAnhua Wu, Seunguk Oh, Stephen M Wiesner, et al.

Blood|November 9, 2006

Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.

Cancer Research|January 17, 2009

De novo induction of genetically engineered brain tumors in mice using plasmid DNAStephen M Wiesner, Stacy A Decker, Jon D Larson, et al.

Haematologica|July 16, 2016

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyZohar Sachs, Raha A Been, Krista J DeCoursin, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

American Journal of Hematology|June 18, 2011

Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeStephen M Wiesner, Jennifer L Geurts, Miechaleen D Diers, et al.

Stem Cells and Development|February 15, 2008

Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like propertiesAnhua Wu, Seunguk Oh, Stephen M Wiesner, et al.

Blood|November 9, 2006

Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.

Cancer Research|January 17, 2009

De novo induction of genetically engineered brain tumors in mice using plasmid DNAStephen M Wiesner, Stacy A Decker, Jon D Larson, et al.

Haematologica|July 16, 2016

Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiencyZohar Sachs, Raha A Been, Krista J DeCoursin, et al.

Pageof 2